BTK Inhibitor Reduces Brain Lesions in Relapsing MS
Subgroup analysis shows brain penetration
Stay updated with breaking news from Disability Status Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Subgroup analysis shows brain penetration
For newly diagnosed patients with multiple sclerosis (MS), obesity is associated with higher disease severity and poorer outcomes.
For newly diagnosed patients with multiple sclerosis (MS), obesity is associated with higher disease severity and poorer outcomes.
Hippotherapy simulation may become a nonpharmacological intervention for people with MS that can improve muscle strength and spasticity.
Message : Required fields -- 85% of treatment-naïve, early-stage relapsing-remitting multiple sclerosis (RRMS) patients achieved no evidence of disease activity (NEDA) in open-label Phase IIIb ENSEMBLE study -- OCREVUS significantly slowed loss of brain tissue within T2 MRI lesions in primary progressive multiple sclerosis (PPMS) in post-hoc analysis of Phase III ORATORIO study -- OCREVUS-treated patients show highest adherence and persistence rates compared with other disease-modifying therapies (DMTs) in two-year U.S. claims analysis ...